Plug-and-play biotech procurement infrastructure that helps portfolio companies spend smarter, scale faster, and stay lean from seed to exit.
Leading investors trust portfolio companies running on MyAmici to deploy capital efficiently and scale fast.
MyAmici delivers the kind of performance metrics investors notice for all the right reasons.
Investors want lean teams that deploy capital with discipline. MyAmici replaces costly back-office build-out with a ready-to-run lab ops stack – procurement, HSE approvals, inventory, asset management, and reporting – so founders keep headcount light and scientists focused on science.
Biotech paths evolve quickly, from discovery to clinic to GMP. MyAmici lets companies adapt their operating model without re-wiring the business: shift spend priorities, scale categories, tighten controls, and sunset non-core activity fast.
See how our biotech procurement platform simplifies purchasing, saves money, and gives time back to science.
MyAmici is a turnkey solution: proven software, expert people, supplier access, and CapEx know-how to source, procure, and manage the delivery of critical equipment so scientists are productive on day one. We’ve even aligned with investor “fast-start” programs to accelerate setup and get labs operational the moment funding lands.
We work across hundreds of biotechs, so we know what excellent looks like. MyAmici brings that pattern knowledge to each portfolio company, sharing what’s working elsewhere so they avoid first-timer mistakes, negotiate stronger, and embed investor-grade operating discipline from the start.
From lab benches to boardrooms, MyAmici is delivering value where it counts. Dive into our case studies to see how we make it happen.
Dive into a curated mix of thought leadership, industry insight, and behind-the-scenes biotech lab wins.
MyAmici gives investors visibility and control across their biotech portfolio by standardizing how labs buy, track, and manage spend. With £250M+ in managed biotech procurement, the platform delivers measurable cost savings (typically 20–30%) and faster mobilization for new ventures. That efficiency compounds across your investments, improving capital deployment, reducing burn, and extending runway without adding headcount.
Yes. MyAmici provides a turnkey operational stack — purchasing, inventory, equipment sourcing, and supplier management — that can be live in weeks, not months. This lets new labs get scientists working immediately while maintaining procurement and compliance standards expected by institutional investors. Faster setup means faster proof-of-concept, and a clearer path to the next funding milestone.
Unlike generic ERPs, MyAmici is purpose-built for biotech. It combines deep scientific expertise, 65+ procurement specialists, and a pre-integrated supplier network covering 1,800+ vendors. Labs benefit from a configurable SaaS platform backed by real people who understand the science, not just the spend. The result is faster ROI, less friction, and a system that scales from start-up to GMP without reinvestment in new tools.
MyAmici was designed with audit and investor confidence in mind. The platform enforces digital approval flows, provides full audit trails, and integrates with financial controls for accurate reporting. It helps portfolio companies meet GMP, ISO, and financial compliance requirements — reducing audit risk, improving traceability, and ensuring capital is used exactly where it should be.
Absolutely. MyAmici scales with your portfolio — from first lab setup to global manufacturing. Start-ups use it to avoid the chaos of manual purchasing; mid-stage biotechs use it to optimize spend and control complexity; enterprise labs use it to maintain compliance and operational consistency across regions. Wherever a company is in its growth journey, MyAmici helps investors ensure efficiency, accountability, and performance.
See how Amici simplifies procurement, streamlines ops, and saves you money, all in one platform built for biotech.